Cargando…

Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains

Rifampicin (RIF) is one of the most important first-line anti-tuberculosis (TB) drugs, and more than 90% of RIF-resistant (RR) Mycobacterium tuberculosis clinical isolates belong to multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB. In order to identify specific candidate target prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullah, Nadeem, Hao, Ling, Banga Ndzouboukou, Jo-Lewis, Chen, Shiyun, Wu, Yaqi, Li, Longmeng, Borham Mohamed, Eman, Hu, Yangbo, Fan, Xionglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157059/ https://www.ncbi.nlm.nih.gov/pubmed/34063426 http://dx.doi.org/10.3390/pathogens10050607

Ejemplares similares

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
por: Ullah, Nadeem, et al.
Publicado: (2020)

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020)

Formulation in DDA-MPLA-TDB Liposome Enhances the Immunogenicity and Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection
por: Tian, Maopeng, et al.
Publicado: (2018)

Heterologous Boost Following Mycobacterium bovis BCG Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection
por: Wu, Yaqi, et al.
Publicado: (2018)

Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery
por: Hao, Ling, et al.
Publicado: (2020)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
por: Zhang, Yandi, et al.
Publicado: (2021)

A Multistage Subunit Vaccine Effectively Protects Mice Against Primary Progressive Tuberculosis, Latency and Reactivation
por: Ma, Jilei, et al.
Publicado: (2017)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
por: Lei, Qing, et al.
Publicado: (2021)

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
por: Bahraminia, F., et al.
Publicado: (2021)

Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2020)

Characterization of plasma proteins in children of different Mycobacterium tuberculosis infection status using label-free quantitative proteomics
por: Li, Jieqiong, et al.
Publicado: (2017)

Mycobacterium tuberculosis RbpA protein is a new type of transcriptional activator that stabilizes the σ(A)-containing RNA polymerase holoenzyme
por: Hu, Yangbo, et al.
Publicado: (2012)

Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis
por: Yzquierdo, Sergio Luis, et al.
Publicado: (2006)

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
por: Ogwang, Sam, et al.
Publicado: (2009)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Resistance of Mycobacterium tuberculosis strains to Rifampicin: A systematic review and meta-analysis
por: Feyisa, Seifu Gizaw, et al.
Publicado: (2019)

LipF increases rifampicin and streptomycin sensitivity in a Mycobacterium tuberculosis surrogate
por: Arriaga-Guerrero, Ana Leticia, et al.
Publicado: (2020)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
por: Jaleta, Kefyalew N, et al.
Publicado: (2017)

Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia
por: Ali, Mohamed Muhumed, et al.
Publicado: (2023)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Detection of Rifampicin Resistance in Mycobacterium tuberculosis by Padlock Probes and Magnetic Nanobead-Based Readout
por: Engström, Anna, et al.
Publicado: (2013)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR
por: Sahebi, Leyla, et al.
Publicado: (2016)

Utility of the REBA MTB-rifa® assay for rapid detection of rifampicin resistant Mycobacterium Tuberculosis
por: Cho, Eunjin, et al.
Publicado: (2013)

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India
por: Munir, Asma, et al.
Publicado: (2019)

Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid
por: Tang, Peijun, et al.
Publicado: (2017)

Frequency of genomic mutations mediating resistance of Mycobacterium tuberculosis isolates to rifampicin in Northern Morocco
por: Karimi, Hind, et al.
Publicado: (2020)

Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates
por: Muthaiah, Muthuraj, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gitnurku3nf2bpg30jlan0joct